Navigation Links
Lung Bypass Could Fight Emphysema
Date:10/25/2007

Technique allows trapped air a way out, experts say

THURSDAY, Oct. 25 (HealthDay News) -- Airway bypass to treat emphysema patients shows promise, researchers say.

Emphysema, a component of chronic obstructive pulmonary disease (COPD), is a progressive, irreversible lung disease characterized by the destruction of lung tissue. Treatment options are limited.

The new strategy, called airway bypass, is a minimally invasive, catheter-based bronchoscopic technique designed to reduce lung overinflation and improve breathlessness. It does so by making new pathways for trapped air to exit the lungs, according to background information in the study.

During airway bypass, new openings are created in the airway wall connecting the damaged lung tissue to the natural airway. These new pathways are supported and kept open by Exhale Drug-Eluting Stents.

This feasibility study, published in the October issue of the Journal of Thoracic and Cardiovascular Surgery, found that patients showed a statistically significant reduction in the amount of air trapped in the lungs, as well as an improvement in breathing for patients at six months after the procedure.

The results were released by Broncus Technologies Inc, the maker of the Exhale stents.

More information

The American Lung Association has more about emphysema.



-- Robert Preidt



SOURCE: Broncus Technologies Inc., news release, October 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. Older Men Surviving Coronary Bypasses
3. Heart bypass-mental decline link
4. Screening bypasses radical breast surgery
5. Bypass Surgery & Pleural Effusion
6. Life after Bypass not so Promising for Women.
7. The Reason For Loss Of Appetite After Gastric Bypass
8. Twisted bypass grafts work better
9. Gastric bypass surgery reduces risk of heart disease
10. Obesity better handled with gastric bypass surgery
11. Bypassing open heart bypass surgery...
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 18, 2017 , ... ... at creating a transparent, verifiable database to help the cannabis industry move towards ... Paragon hopes to deliver a faster technology with lower fees. Paragon will build ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has ... These illustrations show the diversity of the breastfeeding mothers, using bright colors ... of sizes. These illustrations are also available on tote bags, notepads, smartphone cases, ...
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/2/2017)... Calif. , Aug. 2, 2017 ... Continental Who,s Who as a Pinnacle Lifetime Professional ... the Key Account Manager at Turing Pharmaceuticals, AG. ... negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience as ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: